Graves' Disease Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceReduces thyroid antibodies; may help mild Graves ophthalmopathy; supports thyroid function
Supporting Studies (1)
Deficiency associated with autoimmune thyroid disease; immune modulation
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsMay help with hyperthyroid symptoms; inhibits thyroid hormone entry into cells
Supporting Studies (1)
Anti-inflammatory; may support immune regulation; helps with cardiovascular protection
Supporting Studies (1)
Hyperthyroidism increases B vitamin requirements; supports energy metabolism
Supporting Studies (1)
Hyperthyroidism increases bone turnover; calcium/vitamin D support bone health
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Graves' disease is an autoimmune condition where the body produces antibodies (TSI - thyroid stimulating immunoglobulins) that stimulate the thyroid gland to produce too much thyroid hormone (hyperthyroidism). It is the most common cause of hyperthyroidism.
CLASSIC SYMPTOMS:
GRAVES' OPHTHALMOPATHY:
CRITICAL: Graves' disease requires medical treatment. This protocol is SUPPORTIVE ONLY.
STANDARD TREATMENT:
LIFESTYLE CONSIDERATIONS:
* Selenium has evidence specifically for Graves' ophthalmopathy.
* Vitamin D deficiency is common and may affect autoimmune risk.
* L-Carnitine may help with hyperthyroid symptoms.
* Calcium and Vitamin D support bone health (hyperthyroidism increases bone loss).
Expected timeline: Antithyroid medications take 4-8 weeks to normalize thyroid function. Supplements are supportive throughout treatment.
Clinical Perspective
Graves' Disease: Autoimmune hyperthyroidism from TSH receptor stimulating antibodies (TRAb/TSI). Most common cause of hyperthyroidism. Peak incidence 30-50 years; female predominance. Diagnosis: suppressed TSH, elevated free T4/T3, positive TRAb. Ophthalmopathy: ~30%; can be severe (vision-threatening); separate autoimmune process; smoking major risk factor.
CRITICAL: Requires definitive treatment - antithyroid drugs (methimazole first-line), radioactive iodine, or surgery. Beta-blockers for symptom control. Smoking cessation essential especially if eye involvement. Selenium has evidence for mild-moderate ophthalmopathy (EUGOGO trial). Monitor for thyroid storm (medical emergency). Supplements supportive only - don't delay definitive treatment.
* Selenium (B-grade): Ophthalmopathy. EUGOGO RCT: (PMID: 21508145). 100-200mcg daily. Evidence for mild GO.
* Vitamin D (C-grade): Immune modulation. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* L-Carnitine (C-grade): Symptom relief. RCT: (PMID: 11502782). 2-4g daily. Inhibits T3/T4 cell entry.
* Omega-3 (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.
* B-Complex (C-grade): Increased requirements. Review: (PMID: 27450775). Daily.
* Calcium/Vitamin D (C-grade): Bone protection. Review: (PMID: 28332116). 1000-1200mg calcium daily.
Assessment targets: TSH, free T4, free T3, TRAb, clinical symptoms, eye exam if ophthalmopathy, bone density.
Protocol notes: Methimazole: first-line ATD; start 10-30mg daily; titrate to response; PTU only in first trimester pregnancy or thyroid storm. RAI: definitive treatment; causes hypothyroidism; avoid in active ophthalmopathy (can worsen). Surgery: for large goiters, suspicious nodules, severe GO, or preference. Beta-blockers: propranolol for symptom control; especially cardiac symptoms. Ophthalmopathy: selenium for mild-moderate; IV steroids for moderate-severe; orbital decompression for severe; smoking cessation critical. Thyroid storm: medical emergency; high mortality; aggressive treatment needed. Pregnancy: PTU first trimester, then methimazole; close monitoring; TRAb can cross placenta. Remission: ~30-50% remission with ATDs after 12-18 months; TRAb levels predict relapse. Iodine: avoid excess (kelp, contrast dye, amiodarone). Stress: can trigger or exacerbate; stress management helpful. Bone: increased resorption during hyperthyroid state; normalize and protect bone health.